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Background: Managing fungal infections involving deeper
ocular structures such as fungal endophthalmitis remains
a challenge whereby patients with fungal endophthalmitis
often have a poor visual outcome. Indeed, alternative treat-
ments are needed. We investigated the feasibility of using
topically applied voriconazole in the management of fungal
endophthalmitis.
Methods: In a prospective open label study, 10 partici-
pants were recruited from patients scheduled to undergo
elective, posterior segment surgery. Participants received
topical 1% voriconazole solution, preserved with 0.01% ben-
zalkonium chloride, hourly for 4 doses or four times a
day (qid) for 3 days. Vitreous humour was removed during
surgery and analysed by HPLC.
Results: The mean voriconazole concentration after
hourly dosing (n = 5) was 0.4± 0.4g/mL and the mean
sampling time was 2.2± 1.9 h. Almost all the voricona-
zole concentrations from the qid regimen (n = 5) were <
0.1g/mL. Discussion: The data suggest that hourly dosing
is likely to give adequate concentration required to treat
infections associated with most Candida species but not
Aspergillus or Fusarium species.
Conclusion: Topical application of 1% voriconazole eye
drops is able to penetrate into the vitreous humour and
may be useful as an adjunct to intra-vitreal and systemic
voriconazole in the treatment of fungal endophthalmitis.
doi:10.1016/j.ijid.2008.05.752
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Background: Although administration of antifungal
agents, such as itraconazole (ITC) solution, for prophylaxis is
the most promising strategy for the treatment of haemato-
logical malignancies, little is known about the population
pharmacokinetic (PK) parameters. Subjects and Methods:
A clinical study was conducted to identify PK parameters
for the administration of 200mg/day ITC solution used as
prophylaxis for febrile neutropenia in patients undergoing
treatment. The study population comprised six patients.
NONMEM software was used to estimate PK parameters.
Results: Clearance, volume of distribution and the
absorption rate constant were 12.7 L/h, 333 L and 1.72 h-1,
respectively. Assuming a normal distribution, we predicted
the trough concentrations of 94.5% of the patients receiving
200mg/day ITC solution to be >250 ng/mL, indicating that
administration of 200mg/day might be suitable for prophy-
laxis.
Conclusion: These parameters were different from a
previous study to large extent, which may be due to dif-
ferences in intended patients. These differences strongly
suggest that establishment of population pharmacokinetics
is essential for planning a prospective clinical trial. This pilot
study presents a basic PK model of ITC solution in Japanese
haematological patients for the establishment of optimal
administration.
doi:10.1016/j.ijid.2008.05.753
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A renewed outbreak of fungal infections has been noticed
in recent years related to the increased number of patients
hospitalised at the University Hospital Constantza and sus-
ceptibility of this strains to ﬂuconazole and voriconazole
Methods and Materials: The pathological specimens (spu-
tum, swabs from throat and oral cavity, urine drains, cervical
secretions) has been growth on sabouroud medium; stained
smears were microscopically examinated for yeasts. The
isolated species were identiﬁed by api 32c (bio-merieux).
Fungigrame was made on mueller hinton medium supplied
with gam (glucose and blue methylene)
Results: We isolated 150 fungal strains from
1.01.2007—1.01.2008. Candida albicans was isolated
in 64% strains, candida paralopsis 16%; candida glabratra
8%; candida krusei 10%; candida tropicalis 2%. The candida
albicans strains were sensitive to ﬂuconazole 68% and
sensitive to voriconazole in 88%.
Conclusions: 1. The most isolated strains was represen-
tated by strains of candida albicans. 2. The strains of candida
albicans have a lower sensitivity to ﬂuconazole (68%) and the
higher sensitivity at voriconazole (88%) 3.75% of resistant
strains to ﬂuconazole has been sensitive to voriconazole.
doi:10.1016/j.ijid.2008.05.754
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Background: The number of individuals diagnosed with
diabetes mellitus is increasing worldwide. Controversy
